John Burn
John Burn
Professor of Clinical Genetics
Verified email at
Cited by
Cited by
Celecoxib for the prevention of sporadic colorectal adenomas
MM Bertagnolli, CJ Eagle, AG Zauber, M Redston, SD Solomon, KM Kim, ...
New England Journal of Medicine 355 (9), 873-884, 2006
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
Cancer risk associated with germline DNA mismatch repair gene mutations
MG Dunlop, SM Farrington, AD Carothers, AH Wyllie, L Sharp, J Burn, ...
Human molecular genetics 6 (1), 105-110, 1997
Identification of the familial cylindromatosis tumour-suppressor gene
GR Bignell, W Warren, S Seal, M Takahashi, E Rapley, R Barfoot, ...
Nature genetics 25 (2), 160-165, 2000
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
J Cuzick, F Otto, JA Baron, PH Brown, J Burn, P Greenwald, J Jankowski, ...
The lancet oncology 10 (5), 501-507, 2009
Peutz–Jeghers syndrome: a systematic review and recommendations for management
AD Beggs, AR Latchford, HFA Vasen, G Moslein, A Alonso, S Aretz, ...
Gut 59 (7), 975-986, 2010
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
HFA Vasen, G Moeslein, A Alonso, S Aretz, I Bernstein, L Bertario, ...
Gut 57 (5), 704-713, 2008
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
HFA Vasen, G Möslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, ...
Journal of medical genetics 44 (6), 353-362, 2007
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ...
Gut 62 (6), 812-823, 2013
DiGeorge syndrome: part of CATCH 22.
DI Wilson, J Burn, P Scambler, J Goodship
Journal of medical genetics 30 (10), 852-856, 1993
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease
ARJ Curtis, C Fey, CM Morris, LA Bindoff, PG Ince, PF Chinnery, ...
Nature genetics 28 (4), 350-354, 2001
Is the stock exchange a casino?
T Arthur
Economic Affairs 20 (4), 42-45, 2000
European Code Against Cancer and scientific justification: third version (2003)
P Boyle, P Autier, H Bartelink, J Baselga, P Boffetta, J Burn, HJG Burns, ...
Annals of oncology 14 (7), 973-1005, 2003
Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project
J Burn, M Dennis, J Bamford, P Sandercock, D Wade, C Warlow
Bmj 315 (7122), 1582-1587, 1997
Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus
PJ Scambler, D Kelly, E Lindsay, R Williamson, R Goldberg, R Shprintzen, ...
The Lancet 339 (8802), 1138-1139, 1992
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study
J Burn, P Brennan, J Little, S Holloway, R Coffey, J Somerville, NR Dennis, ...
The Lancet 351 (9099), 311-316, 1998
X-linked situs abnormalities result from mutations in ZIC3
M Gebbia, GB Ferrero, G Pilia, MT Bassi, AS Aylsworth, M Penman-Splitt, ...
Nature genetics 17 (3), 305-308, 1997
Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression
MS Cunnington, MS Koref, BM Mayosi, J Burn, B Keavney
PLoS Genet 6 (4), e1000899, 2010
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human
A Ewart-Toland, P Briassouli, JP de Koning, JH Mao, J Yuan, F Chan, ...
Nature genetics 34 (4), 403-412, 2003
Prevalence and architecture of de novo mutations in developmental disorders
DDD Study, JF McRae, S Clayton, TW Fitzgerald, J Kaplanis, E Prigmore, ...
Nature 542 (7642), 433-438, 2017
The system can't perform the operation now. Try again later.
Articles 1–20